Cargando…
Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease
For many years, β-blockers have been considered contraindicated in patients with heart failure (HF) and in those with bronchial asthma or even chronic obstructive pulmonary disease (COPD) although without clear evidence of asthma. Today, despite overwhelming evidence of the usefulness of β-blockers,...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503302/ https://www.ncbi.nlm.nih.gov/pubmed/34650380 http://dx.doi.org/10.1093/eurheartj/suab116 |